Clinical Trial Update: Evaluation of Immediate Release Tablet [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of an immediate-release tablet for invasive aspergillosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Immediate Release Tablet

Snippet

Sponsor: F2G Biotech GmbH | Conditions: Invasive Aspergillosis | Phase 1 | Status: COMPLETED